Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$2.49 - $5.92 $83,415 - $198,320
-33,500 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$4.41 - $12.28 $441 - $1,228
100 Added 0.3%
33,500 $163,000
Q2 2021

Jul 30, 2021

BUY
$10.9 - $14.53 $52,320 - $69,744
4,800 Added 16.78%
33,400 $389,000
Q1 2021

May 06, 2021

SELL
$11.2 - $16.09 $36,960 - $53,097
-3,300 Reduced 10.34%
28,600 $349,000
Q3 2020

Nov 12, 2020

SELL
$15.05 - $23.54 $55,685 - $87,098
-3,700 Reduced 10.39%
31,900 $480,000
Q2 2020

Aug 13, 2020

BUY
$12.7 - $30.73 $284,480 - $688,352
22,400 Added 169.7%
35,600 $873,000
Q1 2020

May 14, 2020

BUY
$9.85 - $22.27 $130,020 - $293,964
13,200 New
13,200 $187,000

Others Institutions Holding CUE

About Cue Biopharma, Inc.


  • Ticker CUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,381,700
  • Market Cap $36.1M
  • Description
  • Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...
More about CUE
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.